Apogee Therapeutics, Inc. (APGE) Develops Antibody TherapiesApogee Therapeutics, Inc.BATS:APGEtraderspro_chartsApogee Therapeutics, Inc. (APGE) develops next-generation antibody therapies for inflammatory and immunology diseases, aiming to deliver longer-lasting and more effective treatments. The company focuses on improving dosing convenience and targeting well-known disease pathways. Growth comes from advancing clinical programs, strong biotech partnerships, and rising demand for better therapies in chronic immune conditions. On the chart, APGE printed a confirmation bar with increasing volume as price moved above the .236 Fibonacci level and into the momentum zone. A trailing stop can be established using Fibonacci levels on the Fibonacci snap tool, helping manage risk while allowing momentum to continue.